VERU INC. Increase (Decrease) in Deferred Revenue
VERU INC. (VERU) reported Increase (Decrease) in Deferred Revenue of -$187.16 thousand for the 12-month period ending 2019-09-30, per its 10-K filed 2019-12-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2020-08-13
- VERU INC. increase (decrease) in deferred revenue for the quarter ending 2019-09-30 was $0.00.
- VERU INC. increase (decrease) in deferred revenue for the quarter ending 2019-06-30 was $0.00.
- VERU INC. increase (decrease) in deferred revenue for the quarter ending 2019-03-31 was -$49.09K.
- VERU INC. increase (decrease) in deferred revenue for the quarter ending 2018-12-31 was -$138.06K.
- VERU INC. increase (decrease) in deferred revenue for fiscal 2019 was -$187.16K.
- VERU INC. increase (decrease) in deferred revenue for fiscal 2018 was -$487.07K, a 148.01% decline from fiscal 2017.
- VERU INC. increase (decrease) in deferred revenue for fiscal 2017 was $1.01M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $0.00 derived: sum of 2 quarters · filed 2020-08-13 | -$49.09K derived: sum of 3 quarters · filed 2020-08-13 | -$187.16K 10-K · filed 2019-12-12 | ||
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | -$49.09K derived: sum of 2 quarters · filed 2020-08-13 | -$187.16K 10-Q · filed 2020-08-13 | -$420.69K derived: sum of 4 quarters · filed 2020-08-13 | ||
| 2019-03-31 | -$49.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | -$187.16K 10-Q · filed 2020-05-13 | -$420.69K derived: sum of 3 quarters · filed 2020-05-13 | -$532.08K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | -$138.06K 10-Q · filed 2020-02-12 | -$153.36K 10-Q · filed 2019-02-13 | -$371.60K derived: sum of 2 quarters · filed 2020-02-12 | -$482.99K derived: sum of 3 quarters · filed 2020-02-12 | -$600.63K derived: sum of 4 quarters · filed 2020-02-12 | |
| 2018-09-30 | -$233.53K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | -$344.92K derived: sum of 2 quarters · filed 2019-12-12 | -$462.57K derived: sum of 3 quarters · filed 2019-12-12 | -$487.07K 10-K · filed 2019-12-12 | -$471.77K 10-K · filed 2018-12-13 | |
| 2018-06-30 | -$111.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | -$229.03K derived: sum of 2 quarters · filed 2019-08-08 | -$253.54K 10-Q · filed 2019-08-08 | -$203.40K derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | -$117.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$142.15K 10-Q · filed 2019-05-15 | -$92.01K derived: sum of 3 quarters · filed 2019-05-15 | |||
| 2017-12-31 | -$24.50K 10-Q · filed 2019-02-13 | $25.63K derived: sum of 2 quarters · filed 2019-02-13 | ||||
| 2017-09-30 | $50.13K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $1.01M 10-K · filed 2018-12-13 | ||||
| 2017-06-30 | $964.38K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |